ORIFARM GENERICS HOLDING A/S: Financial statements 2017
CVR: 27347223
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
ORIFARM GENERICS HOLDING A/S (CVR 27347223) has filed annual accounts for 2017. In 2017, the company reported a gross profit of EUR 701,000 and a net result of EUR 8,507,000 compared with EUR 9,035,000 the year before. That is a decrease of 30.6% compared with the year before. Equity in the 2017 report amounted to EUR 38,490,000. The solvency ratio was 55.6%. The company had 188 employees in the financial year.
- Gross Profit
- EUR 701,000
- Profit/Loss
- EUR 8,507,000
- Equity
- EUR 38,490,000
- Total Assets
- EUR 69,225,000
- Employees
- 188
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 701K EUR | 8.5M EUR | 38.5M EUR | 188 |
| 2016 | - | 1M EUR | 9M EUR | 35M EUR | 165 |
| 2015 | - | 5.7M | 5.2M | 194.3M | - |
| 2014 | - | 8.2M | 4.1M | 15.3M | - |
| 2013 | - | 6.8M | -150K | 11.5M | - |
Official annual report
Keep an eye on ORIFARM GENERICS HOLDING A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
ORIFARM GENERICS HOLDING A/S has published its annual report for 2016. Gross profit came to DKK 1,010,000, and the net result was DKK 9,035,000.
About ORIFARM GENERICS HOLDING A/S
ORIFARM GENERICS HOLDING A/S is a Danish company of the type Aktieselskab based in Odense S, founded in 2003. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named COPYFARM HOLDING A/S. The management consists of Thomas Brandhof. The board consists of Hans Carl Bøgh-Sørensen (chair), Birgitte Bøgh-Sørensen, Mads Fink Eriksen and Nicki Lund Kristensen. The company is owned by ORIFARM GROUP A/S. The company has 0 employees (2016). In 2025, the company reported revenue of DKK 459,463,000 and a net result of DKK 273,125,000 compared with DKK 89,363,000 the year before. Equity in the 2025 report amounted to DKK 2,399,752,000.